Doege, C.; Sedighi, J.; Luedde, M.; Sossalla, S.; Kostev, K.
Negative Association of SGLT2 Inhibitors with Epilepsy Risk Compared with DPP-4 Inhibitors in Type 2 Diabetes: A Target Trial Emulation. Diabetology 2026, 7, 104.
https://doi.org/10.3390/diabetology7060104
AMA Style
Doege C, Sedighi J, Luedde M, Sossalla S, Kostev K.
Negative Association of SGLT2 Inhibitors with Epilepsy Risk Compared with DPP-4 Inhibitors in Type 2 Diabetes: A Target Trial Emulation. Diabetology. 2026; 7(6):104.
https://doi.org/10.3390/diabetology7060104
Chicago/Turabian Style
Doege, Corinna, Jamschid Sedighi, Mark Luedde, Samuel Sossalla, and Karel Kostev.
2026. "Negative Association of SGLT2 Inhibitors with Epilepsy Risk Compared with DPP-4 Inhibitors in Type 2 Diabetes: A Target Trial Emulation" Diabetology 7, no. 6: 104.
https://doi.org/10.3390/diabetology7060104
APA Style
Doege, C., Sedighi, J., Luedde, M., Sossalla, S., & Kostev, K.
(2026). Negative Association of SGLT2 Inhibitors with Epilepsy Risk Compared with DPP-4 Inhibitors in Type 2 Diabetes: A Target Trial Emulation. Diabetology, 7(6), 104.
https://doi.org/10.3390/diabetology7060104